3662
F. Bellotta et al. / Tetrahedron 65 (2009) 3659–3663
mixture was warmed to 23 ꢁC, held at that temperature for 2 h, and
then cooled to 0 ꢁC where excess hydride was quenched by the
careful addition of 3 N aqueous HCl solution. The mixture was
stirred for 2 h at 0 ꢁC and then extracted with diethyl ether
(3ꢂ25 mL). The combined organic extracts were washed sequen-
tially with 3 N aqueous HCl solution (25 mL), 2 N aqueous NaOH
solution (25 mL), and brine. The combined organic extracts were
dried (MgSO4) and concentrated. Purification of the residue by
silica gel chromatography (99% hexane–ethyl acetate) afforded al-
cohol (R,R)-10 as a highly viscous, colorless oil (510 mg, 88%). Rf (5%
in vacuo and the residue was purified by column chromatography
on silica gel (100% hexane) to give the desired silylether derivative
(S,R,R,R)-11 (1.03 g, 92% over two steps) as colorless solid. Rf (hex-
ane) 0.99; [
a
]D¼ þ13.0 (c 9.8, CDCl3); 1H NMR (400 MHz, CDCl3)
d:
5.77 (1H, m, CH2]CH), 4.97 (2H, m, CH2]CH), 3.36 (1H, m, CHOSi),
2.34 (1H, m, ]CHCHMe), 1.70 (1H, m, OCHCHMe), 1.53 (1H, m,
CH2CHMe), 1.37 (2H, m, CH2), 1.32 (1H, m, CHaHbMe), 1.03 (1H, m,
CHaHbMe), 0.98 (3H, d, J 6.7 Hz, ]CHCHMe), 0.90 (9H, s, Me3CSi),
0.86 (6H, s, CHMe), 0.83 (3H, t, J 7.4 Hz, CH2Me), 0.03 (6H, s, Me2Si);
13C NMR (100 MHz, CDCl3)
d: 142.5, 113.6, 79.5, 42.8, 42.1, 33.9, 31.7,
ethyl acetate/hexane) 0.33; [
(400 MHz, CDCl3)
a
]D¼ þ4.0 (c 8.7, CDCl3); 1H NMR
28.7, 26.2, 19.8, 18.5, 17.6, 15.5, 11.2, ꢀ3.7; HRMS (ESI): calcd for
d
: 3.52 (1H, dd, J 5.1, 10.4 Hz, CHaHbOH), 3.37 (1H,
C18H39OSi: 299.2770; found 299.2750 [MþH]þ.
dd, J 6.8, 10.4 Hz, CHaHbOH), 1.71 (1H, m, HOCH2CHMe), 1.54 (1H,
m, CHMe), 1.42 (1H, m, CHaHb), 1.36 (1H, m, CHaHb), 1.31 (1H, m,
3.10. (2R,3R,4R,6R)-3-Hydroxy-2,4,6-trimethyloctanoic acid (2)
CHaHbMe), 1.05 (1H, m, CHaHbMe), 0.92 (3H, d,
HOCH2CHMe), 0.87 (3H, t, J 7.3 Hz, CH2Me), 0.86 (3H, d, J 6.4 Hz,
CHMe); 13C NMR (100 MHz, CDCl3)
: 68.6, 40.5, 33.1, 31.5, 29.0,
J 6.7 Hz,
To
a stirring solution of (S,R,R,R)-11 (500 mg, 1.68 mmol,
d
1.00 equiv) in dioxane (3.00 mL) and H2O (3.00 mL) was added 4-
methylmorpholine N-oxide (295 mg, 2.52 mmol, 1.50 equiv) and
osmium tetraoxide (2% in H2O, 432 mL, 0.034 mmol, 0.02 equiv).
19.8, 17.3, 11.1; HRMS (ESI): calcd for C8H19O: 131.1436; found
131.1448 [MþH]þ.
After 1 h, NaIO4 (539 mg, 2.52 mmol, 1.50 equiv) was added, and
the suspension was stirred at room temperature for 1.5 h. The re-
action mixture was cooled to 0 ꢁC, and sodium chlorite (608 mg,
6.72 mmol, 4.00 equiv) and sulfamic acid (652 mg, 6.72 mmol,
4.00 equiv) were added, and the resulting bright yellow mixture
was removed from the cold bath and stirred for 2 h. To the mixture
was added 5% aqueous HCl (20 mL), and the resulting solution was
extracted with CH2Cl2 (3ꢂ20 mL). The combined organic extracts
were washed with 5% aqueous HCl (20 mL), dried over MgSO4,
concentrated, and purified by HPLC (Macherey, Nagel; ET 200/4
3.7. (2R,4R)-2,4-Dimethylhexanal 4
To a stirred solution of (R,R)-10 (500 mg, 3.84 mmol, 1.00 equiv),
N-methylmorpholine-N-oxide (899 mg, 7.68 mmol, 2.00 equiv),
and 4 Å molecular sieves (1.92 g) in dry CH2Cl2 (4.00 mL), a catal-
ytic amount of tetrapropylammonium perruthenate (67.5 mg,
0.19 mmol, 0.05 equiv) was added. After stirring the reaction mix-
ture at room temperature for 1 h, it was filtered through Celite
washing with diethyl ether to obtain 481 mg of aldehyde (R,R)-4
(98%), immediately used for Brown’s reaction. Rf (20% ethyl acetate/
Nucleosil 100-5, 5
m
, 250ꢂ4.6 mm) with hexane/AcOEt (75:25, with
hexane) 0.43; 1H NMR (400 MHz, CDCl3)
d: 9.57 (1H, d, J 2.5 Hz,
0.05% TFA) to give pure (R,R,R,R)-2 (tR¼4.0 min, 254 mg, 75%).
CHO), 2.43 (1H, m, COCHMe), 1.72 (1H, m, CHMe), 1.42 (1H, m,
CHaHb), 1.36 (1H, m, CHaHb), 1.36 (1H, m, CHaHbMe), 1.08 (3H, d, J
6.8 Hz, COCHMe), 1.05 (1H, m, CHaHbMe), 0.89 (3H, d, J 7.0 Hz,
[
a
]D¼ þ21.2 (c 7.3, chloroform); 1H NMR (500 MHz, CDCl3)
d: 3.49
(1H, t, J 5.8 Hz, CHOH), 2.74 (1H, quintet, J 7.1 Hz, COCHMe), 1.74
(1H, m, HOCHCHMe), 1.44 (1H, m, CHaCHbMe), 1.40 (1H, m,
CH2CHMe), 1.27 (3H, d, J 7.1 Hz, COCHMe), 1.06 (2H, m, CHaCHbMe
and CHaHb),1.03 (1H, m, CHaHb), 0.97 (3H, d, J 6.8 Hz, HOCHCHMe),
0.91 (3H, d, J 6.2 Hz, CH2CHMe), 0.88 (3H, t, J¼7.3 Hz, CH2Me); 13C
CHMe), 0.88 (3H, t, J 7.4 Hz, CH2Me); 13C NMR (100 MHz, CDCl3)
d:
205.5, 44.1, 37.8, 31.9, 29.1, 19.2, 14.1, 11.1; HRMS (ESI): calcd for
C8H17O: 129.1279; found 129.1290 [MþH]þ.
NMR (125 MHz, CDCl3) d: 180.5, 78.3, 42.3, 37.5, 33.2, 31.5, 27.7,
3.8. (3S,4R,5R,7R)-3,5,7-Trimethyl-1-nonen-4-ol 3
20.4, 16.9, 14.8, 11.0; HRMS (ESI): calcd for C11H23O3: 203.1647;
found 203.1665 [MþH]þ.
A solution of potassium tert-butoxide in dry THF (10.5 mL,
10.5 mmol, 2.80 equiv) was cooled to ꢀ78 ꢁC, and trans-2-butene
(1.35 mL, 15.0 mmol, 4.00 equiv) was added, followed by n-butyl-
lithium (2.5 M, 4.21 mL, 10.5 mmol, 2.80 equiv). The resulting bright
yellow solution was stirred at ꢀ78 ꢁC for 2 min and at ꢀ45 ꢁC for
20 min. The reaction was re-cooled to ꢀ78 ꢁC, and a solution of (ꢀ)-B-
methoxydiisopinocampheylborane (3.79 g, 12.0 mmol, 3.20 equiv) in
dry THF was added. The reaction was stirred for 35 min, and BF3$OEt2
(1.47 mL, 12.0 mmol, 3.20 equiv) was added followed by a pre-cooled
(ꢀ78 ꢁC) solution of (R,R)-4 (481 mg, 3.76 mmol, 1.00 equiv) in dry
THF (5.00 mL). The resulting solution was stirred at ꢀ78 ꢁC for 4 h. The
reaction was diluted with saturated aqueous solution of NaCl (40 mL)
and extracted with ethyl acetate (3ꢂ40 mL). The combined organic
extracts were dried (MgSO4) and concentrated to give a dark liquid
(3.80 g) that was used in the following step without further
purification.
Data for natural 3-hydroxy-2,4,6-trimethyloctanoic acid
(HTMOA): [
CDCl3)
a
]D¼ þ21.8 (c 5.4, chloroform); 1H NMR (500 MHz,
d
: 3.48 (1H, t, J 5.8 Hz, CHOH), 2.74 (1H, quintet, J 7.1 Hz,
COCHMe), 1.72 (1H, m, HOCHCHMe), 1.46 (1H, m, CHaCHbMe), 1.40
(1H, m, CH2CHMe), 1.29 (3H, d, J 7.1 Hz, COCHMe), 1.06 (2H, m,
CHaCHbMe and CHaHb), 1.03 (1H, m, CHaHb), 0.97 (3H, d, J 6.8 Hz,
HOCHCHMe), 0.91 (3H, d, J 6.2 Hz, CH2CHMe), 0.87 (3H, t, J¼7.3 Hz,
CH2Me); 13C NMR (125 MHz, CDCl3)
d: 180.5, 78.3, 42.1, 37.7, 33.4,
31.5, 27.7, 20.4, 16.9, 14.8, 11.0.
Acknowledgements
This work was supported by grants from MIUR (PRIN 2007)
‘Sostanze Naturali ed Analoghi Sintetici con Attivita Antitumorale’
Rome, Italy. NMR spectra were provided by the CSIAS, Centro
Interdipartimentale di Analisi Strumentale, Faculty of Pharmacy,
University of Naples. The staff is acknowledged.
3.9. (3S,4R,5R,7R)-4-O-(tert-Butyl-dimethylsilyl)-3,5,7-
trimethyl-1-nonen-4-ol 11
References and notes
To a stirred solution of homoallylic alcohol 3 (3.80 g) in dry DMF
(20.0 mL) were added TBSCl (25.7 g, 41.3 mmol, 2.00 equiv) and
imidazole (3.36 g, 49.4 mmol, 2.40 equiv) and the mixture was
stirred at room temperature for 24 h. The mixture was diluted with
water (30 mL), and the aqueous layer was extracted with ethyl
acetate (3ꢂ30 mL). The combined organic layer was concentrated
1. (a) Zampella, A.; D’Auria, M. V.; Gomez-Paloma, L.; Casapullo, A.; Minale, L.;
Debitus, C.; Henin, Y. J. Am. Chem. Soc. 1996, 118, 6202–6209; (b) D’Auria, M. V.;
Zampella, A.; Gomez-Paloma, L.; Minale, L.; Debitus, C.; Roussakis, C.; Le Bert, V.
Tetrahedron 1996, 52, 9589–9596.
2. Oku, N.; Gustafson, K. R.; Cartner, L. K.; Wilson, J. A.; Shigematsu, N.; Hess, S.;
Pannell, L. K.; Boyd, M. R.; McMahon, J. B. J. Nat. Prod. 2004, 67, 1407–1411.